RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Lipoprotein subclasses are associated with Hepatic steatosis
Insights from the prospective multicenter imaging study for the evaluation of chest pain (PROMISE) clinical trial
Karady, J., McGarrah, R. W., Nguyen, M., Giamberardino, S. N., Meyersohn, N., Lu, M. T., Staziaki, P. V., Puchner, S. B., Bittner, D. O., Foldyna, B., Mayrhofer, T., Connelly, M. A., Tchernof, A., White, P. J., Nasir, K., Corey, K., Voora, D., Pagidipati, N., Ginsburg, G. S., ... Ferencik, M. (2024). Lipoprotein subclasses are associated with Hepatic steatosis: Insights from the prospective multicenter imaging study for the evaluation of chest pain (PROMISE) clinical trial. American journal of preventive cardiology, 18, Article 100680. https://doi.org/10.1016/j.ajpc.2024.100680
OBJECTIVES: To determine the relationship between lipoprotein particle size/number with hepatic steatosis (HS), given its association with traditional lipoproteins and coronary atherosclerosis.
METHODS: Individuals with available CT data and blood samples enrolled in the PROMISE trial were studied. HS was defined based on CT attenuation. Lipoprotein particle size/number were measured by nuclear magnetic resonance spectroscopy. Principal components analysis (PCA) was used for dimensionality reduction. The association of PCA factors and individual lipoprotein particle size/number with HS were assessed in multivariable regression models. Associations were validated in an independent cohort of 59 individuals with histopathology defined HS.
RESULTS: Individuals with HS (n=410/1,509) vs those without (n=1,099/1,509), were younger (59±8 vs 61±8 years) and less often females (47.6 % vs 55.9 %). All PCA factors were associated with HS: factor 1 (OR:1.36, 95 %CI:1.21-1.53), factor 3 (OR:1.75, 95 %CI:1.53-2.02) and factor 4 (OR:1.49; 95 %CI:1.32-1.68) were weighted heavily with small low density lipoprotein (LDL) and triglyceride-rich (TRL) particles, while factor 2 (OR:0.86, 95 %CI:0.77-0.97) and factor 5 (OR:0.74, 95 %CI:0.65-0.84) were heavily loaded with high density lipoprotein (HDL) and larger LDL particles. These observations were confirmed with the analysis of individual lipoprotein particles in PROMISE. In the validation cohort, association between HS and large TRL (OR: 8.16, 95 %CI:1.82-61.98), and mean sizes of TRL- (OR: 2.82, 95 %CI:1.14-9.29) and HDL (OR:0.35, 95 %CI:0.13-0.72) were confirmed.
CONCLUSIONS: Large TRL, mean sizes of TRL-, and HDL were associated with radiographic and histopathologic HS. The use of lipoprotein particle size/number could improve cardiovascular risk assessment in HS.